{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:01:04Z","timestamp":1791594064567,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U54 AG054345"],"award-info":[{"award-number":["U54 AG054345"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG055104"],"award-info":[{"award-number":["AG055104"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>New genetic and genomic resources have identified multiple genetic risk factors for late-onset Alzheimer\u2019s disease (LOAD) and characterized this common dementia at the molecular level. Experimental studies in model organisms can validate these associations and elucidate the links between specific genetic factors and transcriptomic signatures. Animal models based on LOAD-associated genes can potentially connect common genetic variation with LOAD transcriptomes, thereby providing novel insights into basic biological mechanisms underlying the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed RNA-Seq on whole brain samples from a panel of six-month-old female mice, each carrying one of the following mutations: homozygous deletions of\n                      <jats:italic>Apoe<\/jats:italic>\n                      and\n                      <jats:italic>Clu<\/jats:italic>\n                      ; hemizygous deletions of\n                      <jats:italic>Bin1<\/jats:italic>\n                      and\n                      <jats:italic>Cd2ap<\/jats:italic>\n                      ; and a transgenic\n                      <jats:italic>APOE\u03b54<\/jats:italic>\n                      . Similar data from a transgenic\n                      <jats:italic>APP\/PS1<\/jats:italic>\n                      model was included for comparison to early-onset variant effects. Weighted gene co-expression network analysis (WGCNA) was used to identify modules of correlated genes and each module was tested for differential expression by strain. We then compared mouse modules with human postmortem brain modules from the Accelerating Medicine\u2019s Partnership for AD (AMP-AD) to determine the LOAD-related processes affected by each genetic risk factor.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mouse modules were significantly enriched in multiple AD-related processes, including immune response, inflammation, lipid processing, endocytosis, and synaptic cell function. WGCNA modules were significantly associated with\n                      <jats:italic>Apoe<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      <jats:italic>, APOE\u03b54<\/jats:italic>\n                      ,\n                      <jats:italic>Clu<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      , and\n                      <jats:italic>APP\/PS1<\/jats:italic>\n                      mouse models.\n                      <jats:italic>Apoe<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      <jats:italic>, GFAP-driven APOE\u03b54,<\/jats:italic>\n                      and\n                      <jats:italic>APP\/PS1<\/jats:italic>\n                      driven modules overlapped with AMP-AD inflammation and microglial modules;\n                      <jats:italic>Clu<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      driven modules overlapped with synaptic modules; and\n                      <jats:italic>APP\/PS1<\/jats:italic>\n                      modules separately overlapped with lipid-processing and metabolism modules.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study of genetic mouse models provides a basis to dissect the role of AD risk genes in relevant AD pathologies. We determined that different genetic perturbations affect different molecular mechanisms comprising AD, and mapped specific effects to each risk gene. Our approach provides a platform for further exploration into the causes and progression of AD by assessing animal models at different ages and\/or with different combinations of LOAD risk variants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-019-0351-3","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T12:02:34Z","timestamp":1577361754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Ravi S.","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli","family":"Uyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth R.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-8186","authenticated-orcid":false,"given":"Gregory W.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"issue":"1","key":"351_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1474-4422(12)70259-4","volume":"12","author":"K Bettens","year":"2013","unstructured":"Bettens K, Sleegers K, Van Broeckhoven C. Genetic insights in Alzheimer's disease. Lancet Neurol. 2013;12(1):92\u2013104.","journal-title":"Lancet Neurol"},{"issue":"10","key":"351_CR2","doi-asserted-by":"publisher","first-page":"a006296","DOI":"10.1101\/cshperspect.a006296","volume":"2","author":"RE Tanzi","year":"2012","unstructured":"Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(10):a006296.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"351_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnagi.2014.00075","volume":"6","author":"Y Bouter","year":"2014","unstructured":"Bouter Y, et al. Deciphering the molecular profile of plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer\u2019s Disease by Deep Sequencing. Front Aging Neurosci. 2014;6:75.","journal-title":"Front Aging Neurosci"},{"issue":"6422","key":"351_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/bmj.288.6422.961","volume":"288","author":"MN Rossor","year":"1984","unstructured":"Rossor MN, et al. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed). 1984;288(6422):961\u20134.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"351_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1186\/1471-2164-14-831","volume":"14","author":"HM Jackson","year":"2013","unstructured":"Jackson HM, et al. Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer\u2019s disease. BMC Genomics. 2013;14:831.","journal-title":"BMC Genomics"},{"key":"351_CR6","first-page":"79","volume-title":"Progress in Molecular Biology and Translational Science","author":"L Bertram","year":"2012","unstructured":"Bertram L, Tanzi RE. Chapter 3 - The Genetics of Alzheimer\u2019s Disease. In: Teplow DB, editor. Progress in Molecular Biology and Translational Science; 2012, Academic Press. p. 79\u2013100."},{"key":"351_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2147\/CIA.S51571","volume":"9","author":"E Bagyinszky","year":"2014","unstructured":"Bagyinszky E, et al. The genetics of Alzheimer\u2019s disease. Clin Interv Aging. 2014;9:535\u201351.","journal-title":"Clin Interv Aging"},{"issue":"3","key":"351_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ncl.2007.03.009","volume":"25","author":"N Ertekin-Taner","year":"2007","unstructured":"Ertekin-Taner N. Genetics of Alzheimer\u2019s Disease: A Centennial Review. Neurol Clin. 2007;25(3):611.","journal-title":"Neurol Clin"},{"issue":"2","key":"351_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"L Bertram","year":"2010","unstructured":"Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: Back to the future. Neuron. 2010;68(2):270\u201381.","journal-title":"Neuron"},{"issue":"5123","key":"351_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921.","journal-title":"Science"},{"issue":"9","key":"351_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin E, et al. APOE and ALZHEIMER disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16(9):903\u20137.","journal-title":"Mol Psychiatry"},{"key":"351_CR12","doi-asserted-by":"crossref","unstructured":"Alzheimer's Association. 2018 Alzheimer's disease facts and figures. Alzheimer's Dement. 2018;14(3):367-429.","DOI":"10.1016\/j.jalz.2018.02.001"},{"issue":"12","key":"351_CR13","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"351_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013;153(3):707\u201320.","journal-title":"Cell"},{"key":"351_CR15","first-page":"506873","volume":"1","author":"Y-W Wan","year":"2019","unstructured":"Wan Y-W, et al. Functional dissection of Alzheimer\u2019s disease brain gene expression signatures in humans and mouse models. bioRxiv. 2019;1:506873.","journal-title":"bioRxiv"},{"issue":"2","key":"351_CR16","first-page":"159","volume":"13","author":"DJ Fadale","year":"2003","unstructured":"Fadale DJ, et al. Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase. Hum Mol Genet. 2003;13(2):159\u201370.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"351_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nm.3543","volume":"20","author":"T Hong","year":"2014","unstructured":"Hong T, et al. Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia. Nat Med. 2014;20(6):624\u201332.","journal-title":"Nat Med"},{"issue":"9","key":"351_CR18","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1172\/JCI9037","volume":"106","author":"L McLaughlin","year":"2000","unstructured":"McLaughlin L, et al. Apolipoprotein J\/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest. 2000;106(9):1105\u201313.","journal-title":"J Clin Invest"},{"issue":"10","key":"351_CR19","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1073\/pnas.89.10.4471","volume":"89","author":"JA Piedrahita","year":"1992","unstructured":"Piedrahita JA, et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci. 1992;89(10):4471.","journal-title":"Proc Natl Acad Sci"},{"issue":"5438","key":"351_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1126\/science.286.5438.312","volume":"286","author":"N-Y Shih","year":"1999","unstructured":"Shih N-Y, et al. Congenital Nephrotic syndrome in mice lacking CD2-associated protein. Science. 1999;286(5438):312.","journal-title":"Science"},{"issue":"9","key":"351_CR21","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1523\/JNEUROSCI.18-09-03261.1998","volume":"18","author":"Y Sun","year":"1998","unstructured":"Sun Y, et al. Glial Fibrillary acidic protein\u2013Apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci. 1998;18(9):3261.","journal-title":"J Neurosci"},{"key":"351_CR22","first-page":"741421","volume":"1","author":"SR Chintapaludi","year":"2019","unstructured":"Chintapaludi SR, et al. Staging Alzheimer\u2019s disease in the brain and retina of B6.APP\/PS1 mice by transcriptional profiling. bioRxiv. 2019;1:741421.","journal-title":"bioRxiv"},{"issue":"15","key":"351_CR23","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"1","key":"351_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"1","key":"351_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12(1):323.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"351_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139.","journal-title":"Bioinformatics"},{"issue":"12","key":"351_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"351_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/1471-2105-12-480","volume":"12","author":"D Risso","year":"2011","unstructured":"Risso D, et al. GC-content normalization for RNA-Seq data. BMC Bioinformatics. 2011;12:480.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"351_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics"},{"issue":"1","key":"351_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559.","journal-title":"BMC Bioinformatics"},{"key":"351_CR31","volume-title":"A General Framework for Weighted Gene Co-Expression Network Analysis, in Statistical Applications in Genetics and Molecular Biology","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S. A General Framework for Weighted Gene Co-Expression Network Analysis, in Statistical Applications in Genetics and Molecular Biology; 2005."},{"issue":"5","key":"351_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"Database issue","key":"351_CR33","doi-asserted-by":"publisher","first-page":"D662","DOI":"10.1093\/nar\/gku1010","volume":"43","author":"F Cunningham","year":"2015","unstructured":"Cunningham F, et al. Ensembl 2015. Nucleic Acids Res. 2015;43(Database issue):D662\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"351_CR34","doi-asserted-by":"publisher","first-page":"e1003731","DOI":"10.1371\/journal.pcbi.1003731","volume":"10","author":"Rs Janky","year":"2014","unstructured":"Janky Rs, et al. iRegulon: From a Gene List to a Gene Regulatory Network Using Large Motif and Track Collections. PLoS Comput Biol. 2014;10(7):e1003731.","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"351_CR35","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"key":"351_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.","journal-title":"BMC Bioinformatics"},{"key":"351_CR37","doi-asserted-by":"publisher","first-page":"160089","DOI":"10.1038\/sdata.2016.89","volume":"3","author":"M Allen","year":"2016","unstructured":"Allen M, et al. Human whole genome genotype and transcriptome data for Alzheimer\u2019s and other neurodegenerative diseases. Scientific Data. 2016;3:160089.","journal-title":"Scientific Data"},{"key":"351_CR38","doi-asserted-by":"publisher","first-page":"180142","DOI":"10.1038\/sdata.2018.142","volume":"5","author":"PL De Jager","year":"2018","unstructured":"De Jager PL, et al. A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research. Scientific Data. 2018;5:180142.","journal-title":"Scientific Data"},{"key":"351_CR39","doi-asserted-by":"publisher","first-page":"180185","DOI":"10.1038\/sdata.2018.185","volume":"5","author":"M Wang","year":"2018","unstructured":"Wang M, et al. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease. Scientific data. 2018;5:180185.","journal-title":"Scientific data"},{"key":"351_CR40","first-page":"510420","volume":"1","author":"B Logsdon","year":"2019","unstructured":"Logsdon B, et al. Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach. bioRxiv. 2019;1:510420.","journal-title":"bioRxiv"},{"issue":"3","key":"351_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron. 2009;63(3):287\u2013303.","journal-title":"Neuron"},{"key":"351_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1742-2094-11-111","volume":"11","author":"GA Rodriguez","year":"2014","unstructured":"Rodriguez GA, et al. Human APOE4 increases microglia reactivity at A\u03b2 plaques in a mouse model of A\u03b2 deposition. J Neuroinflammation. 2014;11:111.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"351_CR43","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215(4):1047.","journal-title":"J Exp Med"},{"issue":"33","key":"351_CR44","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1073\/pnas.1711357114","volume":"114","author":"AR Nelson","year":"2017","unstructured":"Nelson AR, Sagare AP, Zlokovic BV. Role of clusterin in the brain vascular clearance of amyloid-\u03b2. Proc Natl Acad Sci. 2017;114(33):8681.","journal-title":"Proc Natl Acad Sci"},{"key":"351_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1756-6606-6-44","volume":"6","author":"X-F Chen","year":"2013","unstructured":"Chen X-F, et al. Transcriptional regulation and its misregulation in Alzheimer's disease. Mol Brain. 2013;6:44.","journal-title":"Mol Brain"},{"issue":"16","key":"351_CR46","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/hmg\/9.16.2383","volume":"9","author":"J Theuns","year":"2000","unstructured":"Theuns J, Van Broeckhoven C. Transcriptional regulation of Alzheimer\u2019s disease genes: implications for susceptibility. Hum Mol Genet. 2000;9(16):2383\u201394.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"351_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jalz.2017.07.754","volume":"14","author":"PA Parcon","year":"2018","unstructured":"Parcon PA, et al. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs. Alzheimer\u2019s Dementia. 2018;14(2):230\u201342.","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"2","key":"351_CR48","first-page":"40","volume":"4","author":"BA Citron","year":"2015","unstructured":"Citron BA, et al. Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer\u2019s disease. Am J Neurodegenerative Dis. 2015;4(2):40\u20138.","journal-title":"Am J Neurodegenerative Dis"},{"key":"351_CR49","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/35099076","volume":"2","author":"AD Sharrocks","year":"2001","unstructured":"Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001;2:827.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"351_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"11","key":"351_CR51","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nn.4126","volume":"18","author":"G Chan","year":"2015","unstructured":"Chan G, et al. Modulation of TREM2 by CD33: a protein QTL study integrates Alzheimer loci in human monocytes. Nat Neurosci. 2015;18(11):1556\u20138.","journal-title":"Nat Neurosci"},{"issue":"2","key":"351_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos RB, et al. ApoE and Clusterin cooperatively suppress A\u03b2 levels and deposition: evidence that ApoE regulates extracellular A\u03b2 metabolism in vivo. Neuron. 2004;41(2):193\u2013202.","journal-title":"Neuron"},{"issue":"19","key":"351_CR53","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1523\/JNEUROSCI.5236-13.2014","volume":"34","author":"FF Roussotte","year":"2014","unstructured":"Roussotte FF, et al. Combined Effects of Alzheimer Risk Variants in the & lt; em & gt; CLU & lt;\/em & gt; and & lt; em & gt; ApoE & lt;\/em&gt; Genes on Ventricular Expansion Patterns in the Elderly. J Neurosci. 2014;34(19):6537.","journal-title":"J Neurosci"},{"issue":"4","key":"351_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L","volume":"50","author":"M Calero","year":"2000","unstructured":"Calero M, et al. Apolipoprotein J (clusterin) and Alzheimer\u2019s disease. Microsc Res Tech. 2000;50(4):305\u201315.","journal-title":"Microsc Res Tech"},{"issue":"3","key":"351_CR55","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47(3):566\u2013581.e9.","journal-title":"Immunity"},{"issue":"10","key":"351_CR56","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","volume":"19","author":"M-S Tan","year":"2013","unstructured":"Tan M-S, Yu J-T, Tan L. Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease. Trends Mol Med. 2013;19(10):594\u2013603.","journal-title":"Trends Mol Med"},{"issue":"11","key":"351_CR57","doi-asserted-by":"publisher","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch CM, et al. Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS One. 2012;7(11):e50976.","journal-title":"PLoS One"},{"issue":"23","key":"351_CR58","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1093\/hmg\/ddv371","volume":"24","author":"JN Cochran","year":"2015","unstructured":"Cochran JN, et al. The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity. Hum Mol Genet. 2015;24(23):6667\u201374.","journal-title":"Hum Mol Genet"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-019-0351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-019-0351-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-019-0351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T19:21:51Z","timestamp":1608837711000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-019-0351-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["351"],"URL":"https:\/\/doi.org\/10.1186\/s13024-019-0351-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/757161","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"30 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments involving mice were conducted in accordance with policies and procedures described in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and were approved by the Institutional Animal Care and Use Committee at The Jackson Laboratory.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have approved of the manuscript and agree with its submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interets.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}